Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00569049 · ClinicalTrials.gov registry record
Molecular Analysis of Breast Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 788
- Enrollment target
NCT00569049: Completed study, sponsored by Stanford University.
NCT00569049 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 788 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00569049 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 788 participants
- Enrollment target
Study Summary
This is a research-based study that is looking at the biologic features of breast tissue, lymph node tissue, or blood in order to study breast cancer development growth, and spread. Through tissue and/or blood samples we hope to gain further knowledge and understanding of how to improve diagnosis and treatment of breast cancer by identifying the molecular markers that predict clinical outcome and response to therapy.
Interventions
- PROCEDURE breast tissue, lymph node tissue or blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 788 participants |
| Start Date | 1996-05 |
| Est. Completion | 2011-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00569049
The ClinicalTrials.gov registry entry for NCT00569049 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 788 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which breast tissue, lymph node tissue or blood is the first listed.
NCT00569049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00569049 about?
NCT00569049 is a clinical study titled "Molecular Analysis of Breast Cancer". This is a research-based study that is looking at the biologic features of breast tissue, lymph node tissue, or blood in order to study breast cancer development growth, and spread. Through tissue and/or blood samples we hope to gain further knowledge and understanding of how to improve diagnosis an...
What is the current status of trial NCT00569049?
This trial is currently completed. The enrollment target is 788 participants. The study started on 1996-05. Estimated completion is 2011-07-01.
What interventions are being tested in trial NCT00569049?
The interventions under investigation include: breast tissue, lymph node tissue or blood (PROCEDURE).
Who is sponsoring clinical trial NCT00569049?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.